品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R025327-1g | 1g | 5~7个工作日 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-isopropylpiperaz... |
98% |
|
|
罗恩 | R025327-250mg | 250mg | 5~7个工作日 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-isopropylpiperaz... |
98% |
|
|
罗恩 | R025327-100mg | 100mg | 5~7个工作日 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-isopropylpiperaz... |
98% |
|
|
阿拉丁 | B301362-100mg | 100mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-isopropylpiperaz... |
≥95% |
|
|
阿拉丁 | B301362-500mg | 500mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-isopropylpiperaz... |
≥95% |
|
|
韶远 | SY018139-1g | 1g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-isopropylpiperaz... |
>97% |
|
|
阿法埃莎 | H52424-250mg | 250mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪, 97% (S)-1-Boc-2-isopropylpiperaz... |
97% |
|
|
阿法埃莎 | H52424-1g | 1g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪, 97% (S)-1-Boc-2-isopropylpiperaz... |
97% |
|
|
毕得 | BD22138-1g | 1g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-Isopropylpiperaz... |
98% |
|
|
毕得 | BD22138-5g | 5g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-Isopropylpiperaz... |
98% |
|
|
毕得 | BD22138-25g | 25g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-Isopropylpiperaz... |
98% |
|
|
毕得 | BD22138-250mg | 250mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-Isopropylpiperaz... |
98% |
|
|
毕得 | BD22138-100mg | 100mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc-2-Isopropylpiperaz... |
98% |
|
|
乐研 | 1039586-250mg | 250mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc- 2-isopropyl-piper... |
98% |
|
|
乐研 | 1039586-1g | 1g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc- 2-isopropyl-piper... |
98% |
|
|
乐研 | 1039586-5g | 5g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc- 2-isopropyl-piper... |
98% |
|
|
乐研 | 1039586-10g | 10g | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc- 2-isopropyl-piper... |
98% |
|
|
乐研 | 1039586-100mg | 100mg | 现货 | 674792-05-3 |
(S)-1-Boc-2-异丙基哌嗪 (S)-1-Boc- 2-isopropyl-piper... |
98% |
|
|